News Snapshot:
Hundreds of thousands of essential workers and other groups considered at high risk in China have been given locally-developed vaccines even as clinical trials had not been fully completed, raising safety concerns among experts Reuters | October 6, 2020 | Updated 16:07 IST The WHO's emergency use listing procedure allows unlicensed vaccines and treatments to be assessed to expedite their availability in public health emergencies China is in talks to have its locally-produced COVID-19 vaccines assessed by the World Health Organization, as a step toward making them available for international use, a WHO official said on Tuesday. Hundreds of thousands...
